Drug Trial Radar · NCT03692715
Antibiotic Prophylaxis Before Shock Wave Lithotripsy
Last checked: Nov 20, 2026Latest source record: Mar 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,732
Actual
Start
Sep 27, 2018
Primary completion
Dec 31, 2024
Study completion Dec 31, 2024
Sponsor
- Lead sponsor
- Clinical Urology and Epidemiology Working GroupGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- University of Helsinki; Helsinki University Central Hospital; Western University, Canada; Centre de recherche du Centre hospitalier universitaire de Sherbrooke; King Abdulaziz University; Hospital Sao Luiz; St. Petersburg State Pavlov Medical University; University Hospital, Basel, Switzerland; Tallaght University Hospital; Tabriz University of Medical Sciences; Dr Cipto Mangunkusumo General Hospital
- First posted
- Oct 2, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a two arm, double blind RCT comparing the use of a single dose ciprofloxacin prior to SWL to saline alone. The multicenter trial will be conducted with a pragmatic emphasis including both high volume and low volume sites internationally.
Conditions
- Ureteral Stones
- Ureteral Calculi
- Nephrolithiasis
Interventions
CiprofloxacinDrug
Oral or intravenous ciprofloxacin prior to shockwave lithotripsy.
PlaceboDrug
identical oral placebo if oral cipro was used, or intravenous saline alone in a blinded fashion if IV cipro was used prior to shockwave lithotripsy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite outcome including positive urine culture, symptoms of cystitis, pyelonephritis or urosepsisTime frame: 7-14 days post-shockwave lithotripsy
Locations
10 sites in 9 countries. Site status is shown where the registry gives one.
Hospital Sao Luiz
São Paulo, Brazil
Western University Hospital
London, Ontario, Canada
University of Sherbrooke
Sherbrooke, Quebec, Canada
Helsinki University Hospital
Helsinki, Finland
Universitas Indonesia - Cipto Mangunkusumo Hospital
Jakarta, Indonesia
Tabriz University of Medical Science
Tabriz, Iran
Tallaght University Hospital
Dublin, Ireland
St Petersburg State Pavlov Medical University
Saint Petersburg, Russia
King Abdulaziz University
Jeddah, Saudi Arabia
Department of Urology, University Hospital Basel
Basel, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.